Stay updated on Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.

Latest updates to the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference2%
- Check16 days agoChange DetectedReplace 'Plasma cell myeloma' with 'Multiple myeloma' and increment version from v3.0.2 to v3.1.0.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page version is updated from v3.0.1 to v3.0.2, and the Back to Top link has been removed.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as a publication related to plasma cell myeloma, while several previous locations and related terms have been removed.SummaryDifference8%
- Check59 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
Stay in the know with updates to Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.